Abstract
Glycoprotein nonmetastatic B/DC-Hil/Osteoactivin on myeloid-derived suppressor cells impairs T lymphocytes through the binding of Syndecan-4, delineating a new checkpoint pair to be targeted perhaps in combination with PD-1/PD-L1 blockage.
Original language | English |
---|---|
Pages (from-to) | 453-454 |
Number of pages | 2 |
Journal | Clinical Cancer Research |
Volume | 25 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jan 15 2019 |
ASJC Scopus subject areas
- Oncology
- Cancer Research